Morpholine → methyl 2-(2-acetylphenyl)-3-cyclohexyl-1H-indole-6-carboxylate
反応式
[CH:1]1[C:11]2[C:10]3=[CH:12][C:13]4[CH:14]=[CH:15][C:16]([C:19]([OH:21])=[O:20])=[CH:17][C:18]=4[N:9]3CC=C[C:5]=2[CH:4]=[CH:3][CH:2]=1.[CH:22]1[C:32]2C3=CC4C=CC(C(O)=O)=CC=4N3C=CC[C:26]=2[CH:25]=[CH:24][CH:23]=1.C1C2C3=CC4C=C[C:58]([C:61](O)=[O:62])=CC=4N3CC(C(O)=O)=CC=2C=CC=1.[CH3:67]N(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C.N1CCOCC1>CS(C)=O>[C:61]([C:5]1[CH:4]=[CH:3][CH:2]=[CH:1][C:11]=1[C:10]1[NH:9][C:18]2[C:13]([C:12]=1[CH:22]1[CH2:32][CH2:26][CH2:25][CH2:24][CH2:23]1)=[CH:14][CH:15]=[C:16]([C:19]([O:21][CH3:67])=[O:20])[CH:17]=2)(=[O:62])[CH3:58]参加物
反応物 6
生成物 1
試薬・触媒・溶媒 1
実験手順
7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-5-methyl-6-(4-morpholinylcarbonyl)-, methyl ester. To a solution of 7H-indolo[2,1-a][2]benzazepine-6,10-dicarboxylic acid, 13-cyclohexyl-5-methyl-, 10-methyl ester (120 mg, 0.28 mmol) in DMSO (3.0 mL), TBTU (135 mg, 0.42 mmol) and DIPEA (0.244 mL, 1.4 mmol) were added. The reaction mixture was stirred at rt for 15 min. Then morpholine (0.037 mL, 0. 42 mmol) was added and the reaction mixture was stirred at rt for overnight. It was then concentrated under reduced pressure and the residue was purified by Prep. reverse phase HPLC to give the title compound as a white solid, (115 mg, 82% yield). MS m/z 499(MH+); 1H NMR (500 MHz, CD3OD) δ ppm Compound exists as a complex mixture of rotamers.
後処理
- stirringthe reaction mixture was stirred at rt for overnight
- concentrationIt was then concentrated under reduced pressure
- customthe residue was purified by Prep
出典と根拠
- ORDレコード
- ord-8a9357df51444150a0e12e23db425a44
- 出典データセット
- uspto-grants-2009_01
- 特許番号
- US07473688B2
反応ノート
読み込み中…